Automation webinar

About this webinar

A selection of this year's Phacilitate Automation SIG participants has kicked off discussion in the build-up to the 2018 SIG event this May. This discussion addressed the adoption, implementation and integration of automated solutions in cell-based therapy manufacturing and supply chains.

You can watch & listen this complimentary webinar online and find out the state of play today and in what direction our ‘next steps’ should take us.


What we have discussed

  • What must be automated? (There are lots of ‘cans’ and ‘shoulds’ and ‘coulds’ - but what about defining some ‘musts’?)
  • What simply can’t be automated?
  • Which way will the sector go, ultimately: ‘islands’ of automation or an all-encompassing automated solution?
  • Does automation have to make the process ‘better’, or only consistent? (What does ‘better’ mean? Is it about efficiency)?
  • Is stepwise automation OK?  


  • David HodlVice President, Business Development, Cell Therapy, Invetech (chair)
  • Dr Vijay Chiruvolu, Vice President of Process Sciences & Engineering, Kite - A Gilead Company
  • Dr Nicholas Medcalf, Innovation Lead - Advanced Therapies, Innovate UK
  • Dr Qasim Rafiq, Associate Professor, Cell & Gene Therapy Bioprocessing, Department of  Biochemical Engineering, University College London
  • Dr Valérie Steenwinckel, Director of Industrialisation, Celyad

The webinar has already took place, you can watch the on-demand version here: